Clarendon Fund Managers investment portfolio

AMPLY Discovery is a UK biotechnology company that combines artificial‑intelligence engines with synthetic‑biology wet‑lab validation to discover novel therapeutics from the largely untapped non‑coding portion of the genome, targeting high‑impact diseases such as cancer and antimicrobial‑resistant infections. Its integrated platform links computational target identification, molecule design and experimental testing to deliver first‑in‑class drug candidates for pharmaceutical partners.

Analytics Engines Limited delivers data‑science and artificial‑intelligence consulting, providing data‑engineering solutions and AI‑strategy development for organisations. It also participates in EU Horizon 2020 research projects, collaborating with public‑sector bodies and academic partners across Europe.